Medicines For Malaria Venture
Clinical trials sponsored by Medicines For Malaria Venture, explained in plain language.
-
New malaria treatment plan put to the test in peru
Disease control CompletedThis study looked at whether a new way to treat Malaria Vivax is practical for healthcare workers in Peru. The plan includes a quick test for a enzyme called G6PD and two medicines, tafenoquine or primaquine, to prevent the malaria from coming back. 187 patients took part, and th…
Sponsor: Medicines for Malaria Venture • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
New malaria drug put to the test in human trial
Knowledge-focused CompletedThis study tested a new experimental malaria drug called MMV367 in 12 healthy adults. Participants were intentionally infected with a controlled, low-level malaria infection to see how well the drug kills the parasite and how safe it is. The goal was to understand the right dose …
Phase: PHASE1 • Sponsor: Medicines for Malaria Venture • Aim: Knowledge-focused
Last updated May 26, 2026 04:17 UTC
-
New Long-Acting malaria shot passes first safety check in healthy volunteers
Knowledge-focused CompletedThis early-stage study tested a single injection of a new long-acting malaria medicine (MMV371) in 32 healthy adults to see if it is safe and how the body processes it. Participants received either the real drug or a placebo, and were monitored for side effects and injection site…
Phase: PHASE1 • Sponsor: Medicines for Malaria Venture • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC